What is the difference between phase 1, 2, and 3 cancer clinical trials

May 19, 2026Written by Navis AI

Understanding Cancer Clinical Trial Phases

Cancer clinical trials are structured in phases, each with different goals and numbers of participants. Here's how they differ:

Phase 1 Trials: Safety & Dosage

Primary Goal: Determine if a new treatment is safe and find the right dose

  • Participants: 20-100 people (usually those with advanced cancer)
  • Focus: Safety, side effects, and how the body processes the drug
  • What happens: Doctors start with a low dose and gradually increase it, watching carefully for toxicity
  • Timeline: 1-2 years typically
  • Success means: The drug is safe enough to test further, not necessarily that it works against cancer

Tell us what’s going on with your cancer. 2 free answers, then a free account.

Phase 2 Trials: Effectiveness & Side Effects

Primary Goal: Does the treatment actually work against the cancer?

  • Participants: 100-500 people with a specific cancer type
  • Focus: Preliminary effectiveness (does it shrink tumors?) and continued safety monitoring
  • What happens: Participants receive the dose determined to be safe in Phase 1; researchers measure tumor response
  • Timeline: 2-3 years typically
  • Success means: The treatment shows promise against the specific cancer being studied

Phase 3 Trials: Comparison & Confirmation

Primary Goal: Prove the new treatment works better than current standard treatment

  • Participants: 1,000-5,000 people (much larger groups)
  • Focus: Comparing the new treatment to the best existing treatment (or placebo in some cases)
  • What happens: Participants are randomly assigned to either the new treatment or standard treatment; outcomes are compared
  • Timeline: 2-3 years or longer
  • Success means: The new treatment is proven effective and may lead to FDA approval

Why This Matters for Patients

Understanding these phases helps you evaluate clinical trial opportunities:

  • Phase 1 = Higher risk, but you're helping establish safety
  • Phase 2 = Some evidence of effectiveness, moderate risk
  • Phase 3 = Strong evidence of benefit, most likely to help you personally

According to the National Cancer Institute (NCI), only about 5% of drugs that enter Phase 1 trials ultimately receive FDA approval, so these phases serve as important filters for safety and effectiveness.

The American Cancer Society emphasizes that participating in clinical trials is a personal decision—some patients benefit directly, while others contribute to knowledge that helps future patients.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Your next question, already answered

Tap to keep going. 2 free answers, then a free account.

Ask Navis about your case

That answer is general. Ask about your specific situation. Answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Sources & medical oversight

  • Built by OpenCancer’s team of physician-scientists and cancer survivors.
  • Last updated May 19, 2026. Informational only — not a substitute for your oncology team.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Services

Services that may help with clinical trials for cancer patients

More questions about General